Biotyping in psychosis : using multiple computational approaches with one data set
Focusing on biomarker identification and using biomarkers individually or in clusters to define biological subgroups in psychiatry requires a re-orientation from behavioral phenomenology to quantifying brain features, requiring big data approaches for data integration. Much still needs to be accomplished, not only to refine but also to build support for the application and customization of such an analytical phenotypic approach. In this review, we present some of what Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has learned so far to guide future applications of multivariate phenotyping and their analyses to understanding psychosis. This paper describes several B-SNIP projects that use phenotype data and big data computations to generate novel outcomes and glimpse what phenotypes contribute to disease understanding and, with aspiration, to treatment. The source of the phenotypes varies from genetic data, structural neuroanatomic localization, immune markers, brain physiology, and cognition. We aim to see guiding principles emerge and areas of commonality revealed. And, we will need to demonstrate not only data stability but also the usefulness of biomarker information for subgroup identification enhancing target identification and treatment development.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:46 |
|---|---|
| Enthalten in: |
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 46(2021), 1 vom: 01. Jan., Seite 143-155 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Tamminga, Carol A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
|---|
| Anmerkungen: |
Date Completed 23.06.2021 Date Revised 05.10.2022 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1038/s41386-020-00849-8 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315505737 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315505737 | ||
| 003 | DE-627 | ||
| 005 | 20231225155049.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/s41386-020-00849-8 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315505737 | ||
| 035 | |a (NLM)32979849 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Tamminga, Carol A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Biotyping in psychosis |b using multiple computational approaches with one data set |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 23.06.2021 | ||
| 500 | |a Date Revised 05.10.2022 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Focusing on biomarker identification and using biomarkers individually or in clusters to define biological subgroups in psychiatry requires a re-orientation from behavioral phenomenology to quantifying brain features, requiring big data approaches for data integration. Much still needs to be accomplished, not only to refine but also to build support for the application and customization of such an analytical phenotypic approach. In this review, we present some of what Bipolar-Schizophrenia Network for Intermediate Phenotypes (B-SNIP) has learned so far to guide future applications of multivariate phenotyping and their analyses to understanding psychosis. This paper describes several B-SNIP projects that use phenotype data and big data computations to generate novel outcomes and glimpse what phenotypes contribute to disease understanding and, with aspiration, to treatment. The source of the phenotypes varies from genetic data, structural neuroanatomic localization, immune markers, brain physiology, and cognition. We aim to see guiding principles emerge and areas of commonality revealed. And, we will need to demonstrate not only data stability but also the usefulness of biomarker information for subgroup identification enhancing target identification and treatment development | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Review | |
| 700 | 1 | |a Clementz, Brett A |e verfasserin |4 aut | |
| 700 | 1 | |a Pearlson, Godfrey |e verfasserin |4 aut | |
| 700 | 1 | |a Keshavan, Macheri |e verfasserin |4 aut | |
| 700 | 1 | |a Gershon, Elliot S |e verfasserin |4 aut | |
| 700 | 1 | |a Ivleva, Elena I |e verfasserin |4 aut | |
| 700 | 1 | |a McDowell, Jennifer |e verfasserin |4 aut | |
| 700 | 1 | |a Meda, Shashwath A |e verfasserin |4 aut | |
| 700 | 1 | |a Keedy, Sarah |e verfasserin |4 aut | |
| 700 | 1 | |a Calhoun, Vince D |e verfasserin |4 aut | |
| 700 | 1 | |a Lizano, Paulo |e verfasserin |4 aut | |
| 700 | 1 | |a Bishop, Jeffrey R |e verfasserin |4 aut | |
| 700 | 1 | |a Hudgens-Haney, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Alliey-Rodriguez, Ney |e verfasserin |4 aut | |
| 700 | 1 | |a Asif, Huma |e verfasserin |4 aut | |
| 700 | 1 | |a Gibbons, Robert |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology |d 1988 |g 46(2021), 1 vom: 01. Jan., Seite 143-155 |w (DE-627)NLM012626821 |x 1740-634X |7 nnns |
| 773 | 1 | 8 | |g volume:46 |g year:2021 |g number:1 |g day:01 |g month:01 |g pages:143-155 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41386-020-00849-8 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 46 |j 2021 |e 1 |b 01 |c 01 |h 143-155 | ||